文献速递消化内镜消化道肿瘤与早癌

小腺瘤与微小腺瘤对异时性进展期腺瘤风险的影响:新罕布什尔结肠镜登记数据

Association of small versus diminutive adenomas and the risk for metachronous advanced adenomas: data from the New Hampshire Colonoscopy Registry.
PubMed 文献 · Gastrointest Endosc · 2019-05-22

基于新罕布什尔结肠镜登记(NHCR)的人群数据,按基线腺瘤大小与数目分组,分析异时性进展期腺瘤(AA)的绝对与校正风险。校正协变量后,含至少1枚5-9 mm小腺瘤者异时性AA风险升高;恰有2枚小腺瘤者绝对风险7.6%(11/144,95%CI 4.3%-13.2%),与3-10枚腺瘤的8.2%(95%CI 5.4%-11.9%)相近。作者认为含至少1枚小腺瘤者可能风险更高、需更密切随访。

要点

  • 1-2枚<1 cm腺瘤中至少含1枚5-9 mm小腺瘤者,异时性AA风险较仅微小腺瘤者升高(AOR 1.54)。
  • 恰有2枚小腺瘤者异时性AA绝对风险7.6%(11/144),与3-10枚腺瘤的8.2%相近。
  • 作者认为含至少1枚小腺瘤者可能需比仅微小腺瘤者更密切的随访。

核心结论

  • 在1-2枚<1 cm腺瘤的个体中,含至少1枚小腺瘤者较仅有微小腺瘤者异时性AA风险升高。
  • 恰有2枚小腺瘤者未来AA风险与3-10枚腺瘤者相近。
  • 作者认为含至少1枚小腺瘤者可能未来AA风险更高,因而需要比仅有微小腺瘤者更密切的随访。
  • 作者认为这些数据可能对指南委员会制定未来监测建议有价值。

研究设计与样本

  • 数据来自全州、基于人群的新罕布什尔结肠镜登记(NHCR)参与者。
  • 按基线所见分为5组:1-2枚<5 mm腺瘤(均为微小)、1-2枚<1 cm腺瘤(1枚或以上为小腺瘤)、3-10枚<5 mm腺瘤(均为微小)、3-10枚<1 cm腺瘤(1枚或以上为小腺瘤)、进展期腺瘤(AA)。
  • AA定义为腺瘤≥1 cm,或伴绒毛成分、高级别上皮内瘤变或结直肠癌(CRC)。
  • 结局为异时性AA的绝对风险与校正风险。
  • 协变量包括年龄、性别、体质指数、CRC家族史、生活方式因素、有无锯齿状息肉及距基线检查时间。

主要发现

  • 与1-2枚微小腺瘤相比,1-2枚腺瘤中至少1枚为5-9 mm者异时性AA风险升高(AOR 1.54;95%CI 1.12-2.11)。
  • 与1-2枚微小腺瘤相比,3-10枚微小腺瘤者异时性AA风险升高(AOR 1.75;95%CI 1.03-2.95)。
  • 与1-2枚微小腺瘤相比,3-10枚<1 cm腺瘤(1枚或以上为小腺瘤)者异时性AA风险升高(AOR 2.14;95%CI 1.39-3.29)。
  • 与1-2枚微小腺瘤相比,基线AA者异时性AA风险升高(AOR 2.77;95%CI 2.05-3.74)。
  • 恰有2枚小腺瘤者未来AA绝对风险为7.6%(11/144)(95%CI 4.3%-13.2%),高于1-2枚微小息肉组,与3-10枚腺瘤的8.2%(95%CI 5.4-11.9)相近。

关键数值与推荐

  • 1-2枚腺瘤且至少1枚为5-9 mm:AOR 1.54(95%CI 1.12-2.11),参照组为1-2枚微小腺瘤。
  • 3-10枚微小腺瘤:AOR 1.75(95%CI 1.03-2.95),参照组为1-2枚微小腺瘤。
  • 3-10枚<1 cm腺瘤(1枚或以上为小腺瘤):AOR 2.14(95%CI 1.39-3.29),参照组为1-2枚微小腺瘤。
  • 基线进展期腺瘤:AOR 2.77(95%CI 2.05-3.74),参照组为1-2枚微小腺瘤。
  • 恰有2枚小腺瘤:异时性AA绝对风险7.6%(11/144)(95%CI 4.3%-13.2%);3-10枚腺瘤:8.2%(95%CI 5.4-11.9)。

临床怎么用

  • 作者认为含至少1枚小腺瘤者可能未来AA风险更高,因而需要比仅有微小腺瘤者更密切的随访。
  • 作者认为这些数据可能对指南委员会制定未来监测建议有价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Limited data are available to investigate the impact of index adenoma size on the risk of metachronous advanced adenomas. Our goal was to examine the impact of having small (5-9 mm) versus diminutive (<5 mm) adenomas on the future risk of advanced adenomas within the categories for polyps <1 cm currently used in the United States: 1 to 2 and 3 or more tubular adenomas. METHODS: We included data from individuals participating in the statewide, population-based New Hampshire Colonoscopy Registry (NHCR). Groups were based on index findings: (1) 1 to 2 adenomas <5 mm (both diminutive), (2) 1 to 2 adenomas <1 cm (one or both small), (3) 3 to 10 adenomas <5 mm (all diminutive), (4) 3 to 10 adenomas <1 cm (one or more small), and (5) advanced adenomas (AA). AAs were defined as adenomas ≥1cm or those with villous elements or high-grade dysplasia or colorectal cancer (CRC). Outcomes were the absolute and adjusted risk of metachronous AAs. Covariates included age, sex, body mass index, family history of CRC, lifestyle factors, presence of serrated polyps, and time since the index examination. RESULTS: After adjusting for the covariates, we observed that having 1 to 2 adenomas with at least one 5 to 9 mm adenoma (adjusted odds ratio [AOR], 1.54; 95% confidence interval [CI], 1.12-2.11), 3 to 10 diminutive adenomas (AOR, 1.75; 95% CI, 1.03-2.95), 3 to 10 adenomas <1 cm (1 or more small) (AOR, 2.14; 95% CI, 1.39-3.29) or AAs (AOR, 2.77; 95% CI, 2.05-3.74) were associated with an increased risk for metachronous AA compared with having 1 to 2 diminutive adenomas. A further stratification of group 2 showed that those with exactly 2 small adenomas had an absolute risk of future AA of 7.6% (11/144) (95% CI, 4.3%-13.2%), higher than the absolute risk in the 1 to 2 diminutive polyp group, and similar to the risk for 3 to 10 adenomas of 8.2% (95% CI, 5.4-11.9). CONCLUSIONS: For individuals with 1 to 2 adenomas <1 cm, having at least 1 small adenoma increased the metachronous risk of AA compared with having only diminutive adenomas. Furthermore, the subset with 2 small adenomas had a risk of future AA similar to the risk for 3 to 10 adenomas. These data suggest that individuals with at least 1 small adenoma may be at higher risk for future AAs and thus require closer follow-up than those with only diminutive adenomas. These data may be valuable to guideline committees for the creation of future surveillance recommendations.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Anderson JC, Rex DK, Robinson C, et al. Association of small versus diminutive adenomas and the risk for metachronous advanced adenomas: data from the New Hampshire Colonoscopy Registry. Gastrointest Endosc. 2019. PMID: 31125546. doi:10.1016/j.gie.2019.05.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。